Insights

Leavitt Partners Welcomes Brett Giroir, MD to the Firm

Salt Lake City, March 31, 2021 –Today, Leavitt Partners is pleased to announce that Brett Giroir, MD has joined the firm as a Distinguished Visiting Executive. Dr. Giroir will focus on addressing important healthcare topics such as bio-preparedness, value-based care arrangements, evolving issues with the COVID-19 pandemic, diagnostic testing and more. Brett Giroir, MD is … Read more

New Partnership Launches to Advance Access to Care and Treatment, Improve Outcomes for Individuals with Sickle Cell Disease

Partnership Calls on Policymakers to Implement Proposals in 2020 Landmark Report Washington, D.C. — In recognition of World Sickle Cell Day on June 19th, today more than a dozen organizations representing a diverse cross-section of patient advocates, health professional organizations, health insurers and biopharmaceutical companies announced the launch of the Sickle Cell Disease Partnership. The … Read more

The Opioid Epidemic and State Responses

According to the National Institute on Drug Abuse and the CDC, in 2015 over 33,000 people died from opioid overdose in the United States, and in 2013 prescription opioid abuse cost the U.S. economy approximately $78.5 billion in costs related to health care, crime, and loss of productivity. Opioid abuse and the related overdose deaths are harming individuals, families, the … Read more